GanLum achieved a 97.4% PCR-corrected cure rate compared to 94% with standard of care Novartis’ anti-malaria drug could mark the first major advancement in more than 25 years after it showed ...

Malaria remains one of the leading causes of death among children in sub-Saharan Africa, claiming more than 600,000 lives each year worldwide with limited efficacy in currently available treatments ...

Please provide your email address to receive an email when new articles are posted on . Researchers treated patients with uncomplicated malaria with a single dose of a four-drug combination treatment.

Researchers have uncovered new evidence that challenges long-standing beliefs about asymptomatic malaria infections. The study, led by Monash University's Professor Diana Hansen and published in ...

A child is vaccinated against malaria on September 13, 2019 in Ndhiwa, Homabaya County, Western Kenya during the launch of a malaria vaccine in Kenya. The vaccine (Mosquirix) is the world's first ...

Malaria remains a major public health challenge in Africa, with Nigeria, the Democratic Republic of Congo (DRC), Niger, and ...